Mesirow Financial Investment Management Inc. Has $4.06 Million Stake in Colgate-Palmolive (NYSE:CL)

Mesirow Financial Investment Management Inc. cut its stake in Colgate-Palmolive (NYSE:CLFree Report) by 1.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 44,628 shares of the company’s stock after selling 746 shares during the quarter. Mesirow Financial Investment Management Inc.’s holdings in Colgate-Palmolive were worth $4,057,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently modified their holdings of the stock. Kohmann Bosshard Financial Services LLC purchased a new stake in Colgate-Palmolive in the 4th quarter valued at $26,000. Centricity Wealth Management LLC bought a new stake in shares of Colgate-Palmolive in the 4th quarter worth $27,000. Union Bancaire Privee UBP SA purchased a new stake in shares of Colgate-Palmolive in the fourth quarter valued at about $32,000. Bernard Wealth Management Corp. bought a new position in shares of Colgate-Palmolive during the fourth quarter valued at about $36,000. Finally, Roxbury Financial LLC purchased a new position in Colgate-Palmolive during the fourth quarter worth about $43,000. Institutional investors own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on CL. Wells Fargo & Company decreased their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research note on Tuesday, January 7th. StockNews.com raised Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, March 3rd. TD Cowen cut their price objective on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. Piper Sandler reduced their price objective on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. Finally, Raymond James reiterated an “outperform” rating and set a $105.00 target price (down from $110.00) on shares of Colgate-Palmolive in a research note on Monday, February 3rd. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and twelve have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $101.61.

Get Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Stock Up 3.8 %

Colgate-Palmolive stock opened at $96.84 on Friday. The firm has a 50 day simple moving average of $88.84 and a 200 day simple moving average of $95.22. The company has a current ratio of 0.92, a quick ratio of 0.58 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 1-year low of $85.32 and a 1-year high of $109.30. The firm has a market capitalization of $78.59 billion, a price-to-earnings ratio of 27.51, a P/E/G ratio of 4.20 and a beta of 0.40.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period in the previous year, the firm earned $0.87 earnings per share. On average, analysts predict that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Colgate-Palmolive Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.07%. The ex-dividend date of this dividend was Tuesday, January 21st. Colgate-Palmolive’s payout ratio is 56.82%.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Recommended Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.